Advanced search
Publication Cover
Cell Cycle Volume 10, 2011 - Issue 19
Submit an article Journal homepage
880
Views
26
CrossRef citations to date
0
Altmetric
Extra Views

FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy

Bulbul Pandit University of Illinois at Chicago; Chicago, IL USA
&
Andrei L. Gartel University of Illinois at Chicago; Chicago, IL USACorrespondence[email protected]
Pages 3269-3273 | Received 09 Aug 2011, Accepted 12 Aug 2011, Published online: 01 Oct 2011

References

  • Kalin TV, Ustiyan V, Kalinichenko VV. Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell Cycle 2011; 10:396 - 405; PMID: 21270518; http://dx.doi.org/10.4161/cc.10.3.14709
  • Halasi M, Gartel AL. A novel mode of FoxM1 regulation: positive auto-regulatory loop. Cell Cycle 2009; 8:1966 - 1967; PMID: 19411834; http://dx.doi.org/10.4161/cc.8.12.8708
  • Pandit B, Halasi M, Gartel AL. p53 negatively regulates expression of FoxM1. Cell Cycle 2009; 8:3425 - 3427; PMID: 19806025; http://dx.doi.org/10.4161/cc.8.20.9628
  • Hochstrasser M. Protein degradation or regulation: Ub the judge. Cell 1996; 84:813 - 815; PMID: 8601303; http://dx.doi.org/10.1016/S0092-8674(00)81058-2
  • Adams J. Proteasome a suitable antineoplastic target. Nat Rev Cancer 2004; 4:349 - 360; PMID: 15122206; http://dx.doi.org/10.1038/nrc1361
  • Adams J, Kauffman M. Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest 2004; 22:304 - 311; PMID: 15199612; http://dx.doi.org/10.1081/CNV-120030218
  • Duensing S, Duensing A. Bortezomib: killing two birds with one stone in gastrointestinal stromal tumors. Oncotarget 2010; 1:6 - 8; PMID: 21293050
  • Pandit B, Gartel AL. Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells. PLoS ONE 2011; 6:17110; PMID: 21365012; http://dx.doi.org/10.1371/journal.pone.0017110
  • Neznanov N, Komarov AP, Neznanova L, Stanhope-Baker P, Gudkov AV. Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib. Oncotarget 2011; 2:209 - 221; PMID: 21444945
  • Fulda S. Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link. Oncotarget 2011; 2:418 - 421; PMID: 21789791
  • Kazi A, Lawrence H, Guida WC, McLaughlin ML, Springett GM, Berndt N, et al. Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells. Cell Cycle 2009; 8:1940 - 1951; PMID: 19471122; http://dx.doi.org/10.4161/cc.8.12.8798
  • Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726 - 734; PMID: 16148885; http://dx.doi.org/10.1038/nrc1692
  • Galluzzi L, Kepp O, Kroemer G. Tp53 and MTOR crosstalk to regulate cellular senescence. Aging 2010; 2:535 - 537; PMID: 20876940
  • Ge PF, Zhang JZ, Wang XF, Meng FK, Li WC, Luan YX, et al. Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells. Acta Pharmacol Sin 2009; 30:1046 - 1052; PMID: 19575007; http://dx.doi.org/10.1038/aps.2009.71
  • Janku F, McConkey DJ, Hong DS, Kurzroc R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011; 8:528 - 539; PMID: 21587219; http://dx.doi.org/10.1038/nrclinonc.2011.71
  • Puissant A, Robert G, Auberge P. Targeting autophagy to block hematopoietic malignancies. Cell Cycle 2010; 9:3470 - 3478; PMID: 20703092; http://dx.doi.org/10.4161/cc.9.17.13048
  • Bhat UG, Halasi M, Gartel AL. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS ONE 2009; 4:5592; PMID: 19440351; http://dx.doi.org/10.1371/journal.pone.0005592
  • Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. PLoS ONE 2009; 4:6593; PMID: 19672316; http://dx.doi.org/10.1371/journal.pone.0006593
  • Laoukili J, Stahl M, Medema RH. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 2007; 1775:92 - 102; PMID: 17014965
  • Carr JR, Park HJ, Wang Z, Kiefer MM, Raychaudhuri P. FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res 2010; 70:5054 - 5063; PMID: 20530690; http://dx.doi.org/10.1158/0008-5472.CAN-10-0545

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.